Literature DB >> 17023572

Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence.

Bernardo Rodriguez-Iturbe1, Lili Sepassi, Yasmir Quiroz, Zhenmin Ni, Douglas C Wallace, Nosratola D Vaziri.   

Abstract

Mitochondria are the major source of superoxide (O(2)(-)) in the aerobic organisms. O(2)(-) produced by the mitochondria is converted to hydrogen peroxide by mitochondrial superoxide dismutase (SOD2). Mice with complete SOD2 deficiency (SOD2(-/-)) exhibit dilated cardiomyopathy and fatty liver leading to neonatal mortality, whereas mice with partial SOD2 deficiency (SOD2(+/-)) show evidence of O(2)(-)-induced mitochondrial damage resembling cell senescence. Since earlier studies have provided compelling evidence for the role of oxidative stress and tubulointerstitial inflammation in the pathogenesis of hypertension, we tested the hypothesis that partial SOD2 deficiency may result in hypertension. Wild-type (SOD2(+/+)) and partial SOD2-deficient (SOD2(+/-)) mice had similar blood pressures at 6-7 mo of age, but at 2 yr SOD2(+/-) mice had higher blood pressure. Oxidative stress, renal interstitial T-cell and macrophage infiltration, tubular damage, and glomerular sclerosis were all significantly increased in 2-yr-old SOD2(+/-) mice. High-salt diet induced hypertension in 6-mo-old SOD2-deficient mice but not in wild-type mice. In conclusion, partial SOD2 deficiency results in oxidative stress and renal interstitial inflammation, changes compatible with accelerated renal senescence and salt-sensitive hypertension. These findings are consistent with the pattern described in numerous other models of salt-sensitive hypertension and resemble that commonly seen in elderly humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023572     DOI: 10.1152/japplphysiol.00513.2006

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  53 in total

1.  Therapeutic targeting of mitochondrial superoxide in hypertension.

Authors:  Anna E Dikalova; Alfiya T Bikineyeva; Klaudia Budzyn; Rafal R Nazarewicz; Louise McCann; William Lewis; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2010-05-06       Impact factor: 17.367

2.  Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria.

Authors:  Paul M O'Connor; David D Gutterman
Journal:  Circ Res       Date:  2010-07-09       Impact factor: 17.367

Review 3.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

4.  Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability.

Authors:  Mattias Carlström; En Yin Lai; Zufu Ma; Andreas Steege; Andreas Patzak; Ulf J Eriksson; Jon O Lundberg; Christopher S Wilcox; A Erik G Persson
Journal:  Hypertension       Date:  2010-09-27       Impact factor: 10.190

Review 5.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

Review 6.  Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease.

Authors:  Sergey I Dikalov; Rafal R Nazarewicz
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

Review 7.  Regulation of signal transduction by reactive oxygen species in the cardiovascular system.

Authors:  David I Brown; Kathy K Griendling
Journal:  Circ Res       Date:  2015-01-30       Impact factor: 17.367

8.  The mitochondrial-targeted peptide, SS-31, improves glomerular architecture in mice of advanced age.

Authors:  Mariya T Sweetwyne; Jeffrey W Pippin; Diana G Eng; Kelly L Hudkins; Ying Ann Chiao; Matthew D Campbell; David J Marcinek; Charles E Alpers; Hazel H Szeto; Peter S Rabinovitch; Stuart J Shankland
Journal:  Kidney Int       Date:  2017-01-04       Impact factor: 10.612

Review 9.  Role of mitochondrial oxidative stress in hypertension.

Authors:  Sergey I Dikalov; Zoltan Ungvari
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

Review 10.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.